1 / 8

Atrial Fibrillation Market Sales Revenue, Growth Factors, Future Trends 2027

The Atrial fibrillation market was valued at US$ 6,446.08 million in 2019 and is expected to grow at a CAGR of 14.0% from 2020 to 2027 to reach US$ 18,085.96 million by 2027.<br>

Alex832
Télécharger la présentation

Atrial Fibrillation Market Sales Revenue, Growth Factors, Future Trends 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Atrial FibrillationMarket Latest Technology, Emerging Technology till 2027 Published Date : May 2022 Email: sales@theinsightpartners.com

  2. Email:sales@theinsightpartners.com Report Studies • Atrial Fibrillation Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Treatment Type (Non-pharmacological, Pharmacological); End User (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories); and Geography

  3. Email:sales@theinsightpartners.com Atrial Fibrillation Market Overview • The Atrial Fibrillation Marketwas valued at US$ 6,446.08 million in 2019 and is expected to grow at a CAGR of 14.0% from 2020 to 2027 to reach US$ 18,085.96 million by 2027. • The global Atrial Fibrillation Market, based on the treatment type, is segmented into non-pharmacological, and pharmacological. In 2019, the non-pharmacological accounted for the largest market share in the global atrial fibrillation market by treatment type owing to common use of surgical devices for the treatment of cardiac arrhythmias. Moreover, medications to treat atrial fibrillation are not always successful and hence non-pharmacological techniques are widely adopted. Thus, owing to these benefits and their wide acceptance of non-pharmacological techniques the non-pharmacological held the largest share in the market. The end user segment is segmented into hospitals, ambulatory surgical centers, and cardiac catheterization laboratories

  4. Email:sales@theinsightpartners.com Key Segment Market Segment By Type:- • By Type (Non - pharmacological and Pharmacological) • End-User (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories) Download Sample

  5. Email:sales@theinsightpartners.com Atrial Fibrillation Market Value CAGR of 14% (2020 - 2027) Download Sample

  6. Email:sales@theinsightpartners.com Company Profiles • Boston Scientific Corporation • Medtronic • AtriCure, Inc • Biosense Webster, Inc. • BOEHRINGER INGELHEIM GMBH • CardioFocus • Abbott • Sanofi • Biotronik Inc. • Bristol-Myers Squibb Company Download Sample

  7. Email:sales@theinsightpartners.com By Geography • North America (the US, Canada, and Mexico) • Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) • Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) • Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) • South & Central America (Brazil, Argentina, and the Rest of South & Central America).

  8. THANKYOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com

More Related